ECDC published November European monthly measles monitoring report (EMMO). The report highlights that the measles epidemic in Europe continues.
The number of new cases is expected to increase in the beginning of 2012 and peak in the February to May period, in the absence of effective interventions.
Measles, a highly infectious vaccine-preventable disease, is re-emerging in Europe. Countries within the European Region of the World Health Organization, which include EU and EEA/EFTA countries, have committed to eliminate measles by 2015. Elimination of measles requires sustained vaccination coverage above 95% with two doses of a measles-containing vaccine (MCV).
ECDC is monitoring measles transmission in these countries and produces epidemiological updates. The EMMO aims to provide timely public updates on the measles situation in Europe for effective disease control measures, and in support of the common 2015 measles elimination target.
In September 2011, the coordination of surveillance of measles and other vaccine-preventable diseases was transferred from the Statens Serum Institut in Denmark (the former EUVAC.NET hub coordinator) to ECDC; the EUVAC.NET website migrated to ECDC and is now maintained and moderated by ECDC. In October the EUVAC.NET Forum was replaced by EPIS–VPD, an ECDC-moderated platform for the rapid exchange of confidential information on vaccine-preventable diseases.
Read the European monthly measles monitoring report (EMMO), November 2011
See measles maps and surveillance tables and figures
See the video '95% vaccination coverage for a measles-free EU' on ECDC TV